Literature DB >> 21533592

Successful treatment of an intra-abdominal desmoid tumor with irinotecan, fluorouracil, and leucovorin plus bevacizumab in a patient with familial adenomatous polyposis.

Leonardo Atem Costa1, Loureno Cezana, Thiago Bueno Oliveira, Aldo Lourenço Dettino, Maria Dirlei Begnami, Clovis Antônio Pinto, Marcello Ferretti Fanelli, Celso Abdon Mello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21533592     DOI： 10.1007/s00384-011-1201-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  19 in total

1.  Desmoid tumors respond to chemotherapy: defying the dogma in oncology.

Authors:  Shreyaskumar R Patel; Robert S Benjamin
Journal:  J Clin Oncol       Date:  2005-12-05       Impact factor: 44.544

2.  Desmoid tumors -- a characterization of patients seen at Mayo Clinic 1976-1999.

Authors:  Taya Fallen; Marcia Wilson; Bruce Morlan; Noralane M Lindor
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

3.  Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).

Authors:  Veridiana Pires de Camargo; Mary L Keohan; David R D'Adamo; Cristina R Antonescu; Murray F Brennan; Samuel Singer; Linda S Ahn; Robert G Maki
Journal:  Cancer       Date:  2010-05-01       Impact factor: 6.860

Review 4.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

5.  Successful chemotherapeutic modality of doxorubicin plus dacarbazine for the treatment of desmoid tumors in association with familial adenomatous polyposis.

Authors:  Makoto Gega; Hidenori Yanagi; Reigetsu Yoshikawa; Masafumi Noda; Hiroki Ikeuchi; Kiyoshi Tsukamoto; Tsutomu Oshima; Yoshinori Fujiwara; Nobuhisa Gondo; Kazuo Tamura; Joji Utsunomiya; Tomoko Hashimoto-Tamaoki; Takehira Yamamura
Journal:  J Clin Oncol       Date:  2006-01-01       Impact factor: 44.544

6.  Risk factors for development of desmoid tumours in familial adenomatous polyposis.

Authors:  J H Lefevre; Y Parc; S Kernéis; N Goasguen; M Benis; R Parc; E Tiret
Journal:  Br J Surg       Date:  2008-09       Impact factor: 6.939

7.  A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases.

Authors:  E Stoeckle; J M Coindre; M Longy; M Bui Nguyen Binh; G Kantor; M Kind; C Tunon de Lara; A Avril; F Bonichon; B Nguyen Bui
Journal:  Eur J Surg Oncol       Date:  2008-08-29       Impact factor: 4.424

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

Authors:  Anika Hansmann; Claudia Adolph; Tilmann Vogel; Andreas Unger; Gabriela Moeslein
Journal:  Cancer       Date:  2004-02-01       Impact factor: 6.860

10.  Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations.

Authors:  D Speake; D G Evans; F Lalloo; N A Scott; J Hill
Journal:  Br J Surg       Date:  2007-08       Impact factor: 6.939
View more
  1 in total

1.  Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor.

Authors:  Dongxian Jiang; Deming He; Yingyong Hou; Weiqi Lu; Yuan Shi; Qin Hu; Shaohua Lu; Chen Xu; Yalan Liu; Ju Liu; Yunshan Tan; Xiongzeng Zhu
Journal:  Diagn Pathol       Date:  2013-07-31       Impact factor: 2.644
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.